Merck Receives Positive EU CHMP Opinion on ENFLONSIA Label Expansion
The positive opinion would expand the authorization to include vulnerable children up to 24 months old through their second RSV season.
The positive opinion would expand the authorization to include vulnerable children up to 24 months old through their second RSV season.